Cytokinetics, Incorporated (CYTK) Total liabilities 2016–2025
Cytokinetics, Incorporated (CYTK) total liabilities at each fiscal year-end, per SEC filings.
$2.1BFY2025 · since FY2016: $75.8M → $2.1B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $2.1B | +35.6% |
| FY2024 | $1.5B | +27.0% |
| FY2023 | $1.2B | +7.8% |
| FY2022 | $1.1B | +87.9% |
| FY2021 | $597.5M | +42.1% |
| FY2020 | $420.4M | +39.8% |
| FY2019 | $300.8M | +62.4% |
| FY2018 | $185.2M | +0.1% |
| FY2017 | $185.0M | +144.1% |
| FY2016 | $75.8M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice